MX2018001042A - Concentrado que contiene alprostadil. - Google Patents
Concentrado que contiene alprostadil.Info
- Publication number
- MX2018001042A MX2018001042A MX2018001042A MX2018001042A MX2018001042A MX 2018001042 A MX2018001042 A MX 2018001042A MX 2018001042 A MX2018001042 A MX 2018001042A MX 2018001042 A MX2018001042 A MX 2018001042A MX 2018001042 A MX2018001042 A MX 2018001042A
- Authority
- MX
- Mexico
- Prior art keywords
- solvent mixture
- acid
- active ingredient
- concentrate containing
- containing alprostadil
- Prior art date
Links
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000711 alprostadil Drugs 0.000 title abstract 3
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 title abstract 3
- 239000012141 concentrate Substances 0.000 title abstract 2
- 239000011877 solvent mixture Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 238000001802 infusion Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere a una composición farmacéutica líquida en forma de un concentrado para la preparación de una solución para infusión, que contiene alprostadil (prostaglandina E1) como principio activo, disuelto en una mezcla de disolventes de al menos un disolvente orgánico farmacéuticamente aceptable y agua, y se caracteriza porque la proporción de agua total en la mezcla de disolventes se encuentra en el intervalo del 8 al 85 % en peso de H2O, referido a la cantidad total de la mezcla de disolventes, y porque al menos un ácido o una sustancia que actúa de ácido o de donante de protones está contenida como estabilizador para el principio activo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA50666/2015A AT518009A1 (de) | 2015-07-27 | 2015-07-27 | Konzentrat enthaltend Alprostadil |
| PCT/AT2016/060020 WO2017015692A1 (de) | 2015-07-27 | 2016-07-25 | Konzentrat enthaltend alprostadil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018001042A true MX2018001042A (es) | 2018-06-07 |
Family
ID=56852017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001042A MX2018001042A (es) | 2015-07-27 | 2016-07-25 | Concentrado que contiene alprostadil. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3328358B1 (es) |
| AR (1) | AR105504A1 (es) |
| AT (1) | AT518009A1 (es) |
| BR (1) | BR112018001637A2 (es) |
| CO (1) | CO2018000525A2 (es) |
| MX (1) | MX2018001042A (es) |
| PE (1) | PE20180466A1 (es) |
| WO (1) | WO2017015692A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0669966B2 (ja) * | 1989-07-05 | 1994-09-07 | 株式会社ミドリ十字 | 血管造影補助剤 |
| ES2142409T3 (es) * | 1993-10-27 | 2000-04-16 | Upjohn Co | Prostaglandina e 1 estabilizada. |
| DE4342232A1 (de) * | 1993-12-10 | 1995-06-14 | Hexal Pharma Gmbh | Feste Zubereitung für therapeutische Zwecke mit einem Gehalt an Prostaglandin E1 |
| CN102048687A (zh) * | 2009-11-06 | 2011-05-11 | 华北制药集团制剂有限公司 | 一种前列地尔注射液的制备方法 |
| CN103110579B (zh) * | 2013-02-20 | 2014-12-10 | 北京德立福瑞医药科技有限公司 | 前列地尔注射剂 |
-
2015
- 2015-07-27 AT ATA50666/2015A patent/AT518009A1/de not_active Application Discontinuation
-
2016
- 2016-07-25 PE PE2018000129A patent/PE20180466A1/es unknown
- 2016-07-25 EP EP16759666.7A patent/EP3328358B1/de active Active
- 2016-07-25 WO PCT/AT2016/060020 patent/WO2017015692A1/de not_active Ceased
- 2016-07-25 MX MX2018001042A patent/MX2018001042A/es unknown
- 2016-07-25 BR BR112018001637A patent/BR112018001637A2/pt not_active IP Right Cessation
- 2016-07-27 AR ARP160102285A patent/AR105504A1/es not_active Application Discontinuation
-
2018
- 2018-01-19 CO CONC2018/0000525A patent/CO2018000525A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3328358A1 (de) | 2018-06-06 |
| PE20180466A1 (es) | 2018-03-06 |
| WO2017015692A1 (de) | 2017-02-02 |
| AT518009A1 (de) | 2017-06-15 |
| BR112018001637A2 (pt) | 2018-09-18 |
| AR105504A1 (es) | 2017-10-11 |
| CO2018000525A2 (es) | 2018-04-10 |
| EP3328358B1 (de) | 2022-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR121135A2 (es) | Solución no acuosa de regulador(es) de crecimiento vegetal y solvente(s) orgánicos polar(es) y/o semi-polar(es) | |
| MX2016015179A (es) | Una formulación líquida que comprende nicotina para administracion en aerosol. | |
| SG10201806300VA (en) | Liquid pharmaceutical composition | |
| PH12018500690A1 (en) | Novel insulin analogs and use thereof | |
| PE20160681A1 (es) | Formulacion de premezcla de dexmedetomidina | |
| BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
| MX362807B (es) | Formulacion estabilizada de pemetrexed. | |
| MY177820A (en) | Controlled release peptide formulations | |
| MX2020005879A (es) | Composiciones administrables vía intravenosa que comprenden ácidos de grado farmacéutico y reguladores del ph, y el uso de las mismas para tratar enfermedades de disfunción mitocondrial, enfermedades metabólicas y de disfunción del modelado de huesos y tejidos. | |
| MX2012001693A (es) | Formulaciones estables no corrosivas para inhaladores presurizados de dosis medida. | |
| PH12016502544A1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| MX2018001042A (es) | Concentrado que contiene alprostadil. | |
| MX369244B (es) | Solucion alcoholica estable de alprostadilo. | |
| MX2018001041A (es) | Concentrado que contiene alprostadil. | |
| EA201790750A1 (ru) | Назальная лекарственная композиция, содержащая морскую воду в качестве вспомогательного вещества, улучшающего стабильность препарата | |
| BR112015023750A2 (pt) | composição agricolamente ativa concentrada; método de preparação da composição pronta para uso; composição pronta para uso; e método para o tratamento de uma planta | |
| MY203965A (en) | Injectable formulations of paracetamol | |
| NZ797565A (en) | 1-amino-1-cyclopropanecarboxylic acid hydrochloride formulations | |
| AR116488A2 (es) | Composiciones herbicidas de baja volatilidad | |
| HK1239563A1 (en) | Controlled-release formulations | |
| IN2013MU03613A (es) | ||
| EA201500090A1 (ru) | Фармацевтическая композиция, содержащая силденафила цитрат, и способ ее приготовления | |
| UA101467U (uk) | Спосіб збільшення приросту живої маси поросят у підсисний період | |
| IN2014MU01178A (es) | ||
| EA201500198A1 (ru) | Стабильная фармацевтическая композиция в форме назального спрея, содержащая кеторолак |